Hormone Report Interpretation - Mrs. Shital Kumari, 26 years

Results at a Glance

Detailed Interpretation

1. FSH (6.83 mIU/mL) - Normal

2. LH (2.24 mIU/mL) - Normal, but note FSH:LH ratio

3. Prolactin (6.23 ng/mL) - Normal

4. TSH (0.715 uIU/mL) - Normal

5. AMH (2.04 ng/mL) - Normal/Good Ovarian Reserve

Summary Assessment

• No evidence of primary or secondary ovarian failure
• No hyperprolactinemia
• Normal thyroid function
• Good ovarian reserve for her age (AMH 2.04 ng/mL)
• No PCOS pattern (LH is not disproportionately elevated vs FSH)

Important Notes

This interpretation is for educational purposes only. The clinical significance of these results depends heavily on: the day of the menstrual cycle when blood was drawn (ideally Day 2-3 for FSH/LH/AMH), the clinical reason for ordering the tests, the patient's menstrual history, ultrasound findings (antral follicle count), and other investigations. Please consult the treating doctor at AIIMS (Dr. Surabhi Gupta / the Obs & Gynae team) for personalized medical advice.

Recent Fertility Guidelines for Women with Normal Hormone Panels (2023-2026)

Key Guideline Sources Found

1. Definition: When Is a Normal Hormone Panel Not Enough?

• Ovulation confirmation (mid-luteal progesterone or ultrasound tracking)
• Tubal patency (hysterosalpingography or laparoscopy)
• Uterine cavity assessment (sonohysterography or hysteroscopy)
• Semen analysis of the male partner

2. What the ESHRE 2023 Guideline Recommends (52 Recommendations)

• Diagnosis is by exclusion - standard workup must be completed before labelling infertility as "unexplained"
• AMH is recommended for ovarian reserve assessment, but the 2025 Fertility & Sterility editorial now cautions that AMH should NOT be used to predict natural fecundity (a 2.04 ng/mL result like this patient's should not be used to "scare" or "reassure" about natural conception chances)
• First-line treatment for unexplained infertility: IUI (intrauterine insemination) combined with ovarian stimulation - not immediate IVF
• Expectant management (timed intercourse for up to 2 years) is appropriate for young couples (<36 years) with a short duration of infertility
• No treatment has high-quality evidence behind it in UI; most recommendations are based on low or very low certainty evidence

3. WHO 2026 Guideline - Key Points for Normal Hormone Patients

• For unexplained infertility specifically, 6 treatment recommendations were made
• Emphasizes equity - fertility care should be accessible as part of universal health coverage
• Good practice statements stress: listen to patient values, individualize treatment, document outcomes
• Supports complete diagnostic workup before proceeding to assisted reproduction

4. NICE NG257 (March 2026) - Notable Updates

• Now recommends earlier referral for women aged 36+ (reduced from previous thresholds)
• For women aged 35 and under (like this patient at 26), standard advice remains: try naturally for 12 months before referral
• Advises against routine TSH screening in women without thyroid symptoms (relevant here - her TSH is normal at 0.715)
• Cautions against treating subclinical hypothyroidism in infertile women without symptoms, as evidence for benefit is absent

5. What This Means for a 26-Year-Old with Normal Hormones

Bottom line from current guidelines: A normal hormone panel is reassuring but the fertility workup is not complete without tubal assessment, uterine evaluation, and male factor assessment. For a 26-year-old woman with normal hormones, the most guideline-consistent approach is completing the full diagnostic evaluation and, if all normal, attempting natural conception for up to 12 months before escalating to IUI or IVF. The treating team at AIIMS is best placed to guide next steps based on clinical history and any additional findings.

Clinical Assessment: 2 Years of Trying with Normal Hormones

She Now Meets the Definition of Infertility

Step 1: Is the Workup Complete? (Critical Before Treatment)

Step 2: If Workup Is Normal - Treatment Options

Option A: IUI + Ovarian Stimulation (First-Line)

• Recommended as first-line by ESHRE 2023 for couples with unexplained infertility
• Involves mild ovarian stimulation (clomiphene citrate or low-dose FSH injections) + timed insemination with washed sperm
• Typical success rate: 10-18% per cycle; usually tried for 3-6 cycles
• Lower cost, less invasive than IVF, appropriate starting point for a 26-year-old with good ovarian reserve

Option B: IVF (Second-Line, or First-Line Debate)

IVF did NOT achieve live birth significantly faster than IUI + ovarian stimulation (50.3% vs 43.2% cumulative live birth rate, HR 1.19, 95% CI 0.81-1.74).

Step 3: What Else May Be Found

• Chronic endometritis - found in ~57% of unexplained infertility cases; treatable with antibiotics (doxycycline), with significantly improved live birth rates after treatment
• Undiagnosed pelvic pathology (endometriosis, adhesions) - detected only by laparoscopy, found in up to 50% of women with unexplained infertility
• Uterine natural killer cell imbalance / immune factors - active research area, no reliable screening test yet
• Ureaplasma/Mycoplasma infection in either partner - worth screening

Recommended Roadmap for Mrs. Shital Kumari

Current status: 2 years infertility, normal hormones
↓
1. Complete workup at AIIMS:
   - Confirm ovulation (Day 21 progesterone or follicle scan)
   - HSG or HyCoSy (tubal patency)
   - Pelvic ultrasound / sonohysterography (uterine cavity)
   - Partner semen analysis
↓
2. If all normal → Diagnosis: Unexplained Infertility
   - Consider endometrial biopsy (chronic endometritis)
   - Consider laparoscopy if clinical suspicion of endometriosis
↓
3. First-line treatment:
   IUI + Ovarian Stimulation (3-6 cycles)
   ~10-18% success per cycle
↓
4. If IUI fails after 3-6 cycles:
   Proceed to IVF/ICSI
   (Cumulative live birth rate ~50% with IVF in unexplained infertility)

Key Numbers to Know

Important: This overview is based on published guidelines and evidence. Mrs. Shital Kumari's AIIMS team (Dr. Surabhi Gupta, Obs & Gynae) is in the best position to recommend treatment after reviewing her full history, her partner's semen analysis, and any remaining investigations. She should not delay her follow-up appointment.

Secondary Infertility - Revised Assessment for Mrs. Shital Kumari

What Is Secondary Infertility?

Why Her Normal Hormone Panel Is Even More Reassuring Now

Most Likely Causes to Investigate (in priority order)

🔴 High Priority - Related to the Previous Pregnancy/Delivery

🟡 Medium Priority - Could Have Developed Since First Pregnancy

🟢 Lower Priority (Already Largely Ruled Out)

• Ovarian/hormonal causes - her panel is normal ✅
• Thyroid dysfunction - TSH 0.715 is normal ✅
• Hyperprolactinemia - Prolactin 6.23 is normal ✅
• Diminished ovarian reserve - AMH 2.04 ng/mL is good ✅

One Critical Question the Report Doesn't Answer

Recommended Investigation Path

Previous child (vaginal or C-section?) 
        ↓
1. Transvaginal ultrasound
   → Uterine cavity, fibroids, polyps, C-section niche
        ↓
2. Partner semen analysis
   → Rule out new male factor (easy, non-invasive, do early)
        ↓
3. Ovulation confirmation
   → Day 21 progesterone or follicle tracking scan
        ↓
4. Tubal assessment
   → HSG or HyCoSy (especially important if previous C-section/PID risk)
        ↓
5. Hysteroscopy (if uterine cause suspected)
   → Best for Asherman's, endometrial polyps, CSD niche
        ↓
6. Endometrial biopsy
   → If all structural causes excluded (chronic endometritis)
        ↓
7. Laparoscopy (if still unexplained)
   → Endometriosis, adhesions, peritubal pathology

Treatment Will Depend on What Is Found

• Asherman's / uterine adhesions - hysteroscopic adhesiolysis; good pregnancy rates after treatment
• C-section niche - hysteroscopic or laparoscopic repair; improves implantation
• Chronic endometritis - 2-4 weeks of doxycycline; significantly improves live birth rates
• Tubal blockage - laparoscopic tuboplasty or IVF bypass
• New male factor - depends on finding (lifestyle, IUI, ICSI)
• Endometriosis - laparoscopic excision + IUI or IVF depending on severity

Key takeaway: Secondary infertility with a normal hormone panel in a 26-year-old almost always has a structural cause related to the previous pregnancy - especially intrauterine adhesions, C-section scar defect, or chronic endometritis. These are all diagnosable and treatable. The AIIMS team is well-equipped to work through this systematically. Asking the treating doctor specifically about uterine cavity assessment (hysteroscopy/sonohysterography) as the next priority would be very reasonable.